Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2012

01.09.2012

Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors

verfasst von: Erin Ebbel Niemasik, Joseph Letourneau, Daniel Dohan, Audra Katz, Michelle Melisko, Hope Rugo, Mitchell Rosen

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We sought to determine what women recall about reproductive health risks (RHR) from cancer therapy at the time of cancer diagnosis in order to identify barriers to reproductive health counseling (RHC) and fertility preservation (FP).

Methods

Data were obtained by surveying 1,041 female cancer survivors from the California Cancer Registry. Inclusion criteria included women age 18–40 with a diagnosis of leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma, breast or GI cancer diagnosed between 1993 and 2007. Women were asked to respond to an open-ended question: “what did your doctor tell you about how cancer treatment could affect your ability to get pregnant?” Framework analysis was used to identify themes surrounding patient perceptions of RHC.

Results

Of the patients, 51.8 % (361 out of 697) recalled receiving reproductive health counseling and 12.2 % (85 out of 697) recalled receiving FP counseling. Of the patients, 45.3 % (277 out of 612) reported that uncertain prognosis, risk of recurrence or vertical transmission, age, parity, or uncertain desire may have prevented them from receiving timely and essential information on RHRs. Communication barriers included omission of information, failure to disclose RHRs, and presentation of incorrect information on FP.

Discussion

In a sample of women diagnosed with cancer of reproductive age, almost half did not recall counseling on RHRs and few recalled FP counseling. Communication barriers between physicians and patients regarding fertility may lead to uninformed (reproductive health) RH decisions.

Implications for cancer survivors

Many women may not receive adequate information about RHRs or FP at the time of cancer diagnosis. Advancements in reproductive technology and emerging organizations that cover financial costs of FP have dramatically changed what options women have to preserve their fertility. Routine and thoughtful RHR and FP counseling, as well as collaborative cancer care will help ensure that women diagnosed with cancer are provided with the services and information they need to make an informed choice about their reproductive future.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009;53:281–4.PubMedCrossRef Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer. 2009;53:281–4.PubMedCrossRef
3.
Zurück zum Zitat Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–83.PubMedCrossRef Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–83.PubMedCrossRef
4.
Zurück zum Zitat Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.PubMedCrossRef Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.PubMedCrossRef
5.
Zurück zum Zitat Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–8.CrossRef Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–8.CrossRef
6.
Zurück zum Zitat Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer. 1999;86:697–709.PubMedCrossRef Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer. 1999;86:697–709.PubMedCrossRef
7.
Zurück zum Zitat Zebrack BJ, Casillas J, Nohn L, Adams H, Zeltzer LK. Fertility issues for young adult survivors of childhood cancer. Psychooncology. 2004;13:689–99.PubMedCrossRef Zebrack BJ, Casillas J, Nohn L, Adams H, Zeltzer LK. Fertility issues for young adult survivors of childhood cancer. Psychooncology. 2004;13:689–99.PubMedCrossRef
8.
Zurück zum Zitat Jenninga E, Hilders CG, Louwe LA, Peters AA. Female fertility preservation: practical and ethical considerations of an underused procedure. Cancer. 2008;14:333–9.CrossRef Jenninga E, Hilders CG, Louwe LA, Peters AA. Female fertility preservation: practical and ethical considerations of an underused procedure. Cancer. 2008;14:333–9.CrossRef
9.
Zurück zum Zitat Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer. 2011;118(7):1933–9.PubMedCrossRef Letourneau JM, Ebbel EE, Katz PP, Oktay KH, McCulloch CE, Ai WZ, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer. 2011;118(7):1933–9.PubMedCrossRef
10.
Zurück zum Zitat Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008;9:993–1001.PubMedCrossRef Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008;9:993–1001.PubMedCrossRef
11.
Zurück zum Zitat Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol. 2011;8:56–60.PubMedCrossRef Letourneau JM, Melisko ME, Cedars MI, Rosen MP. A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol. 2011;8:56–60.PubMedCrossRef
12.
Zurück zum Zitat Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27:5952–7.PubMedCrossRef Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27:5952–7.PubMedCrossRef
13.
Zurück zum Zitat Creswell JW. Qualitative inquiry & research design: choosing among five approaches. Thousand Oaks: Sage; 2007. Creswell JW. Qualitative inquiry & research design: choosing among five approaches. Thousand Oaks: Sage; 2007.
14.
Zurück zum Zitat Srivastava A, Thomson SB. Framework analysis: a qualitative methodology for applied policy research. JOAAG. 2009;4(2):72–9. Srivastava A, Thomson SB. Framework analysis: a qualitative methodology for applied policy research. JOAAG. 2009;4(2):72–9.
15.
Zurück zum Zitat Sandman L, Munthe C. Shared decision-making and patient autonomy. Theor Med Bioeth. 2009;30(4):289–310.PubMedCrossRef Sandman L, Munthe C. Shared decision-making and patient autonomy. Theor Med Bioeth. 2009;30(4):289–310.PubMedCrossRef
16.
Zurück zum Zitat Elwyn G, Edwards A, Hood K, Robling M, Atwell C, Russell I, et al. Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract. 2004;21(4):337–46.PubMedCrossRef Elwyn G, Edwards A, Hood K, Robling M, Atwell C, Russell I, et al. Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Fam Pract. 2004;21(4):337–46.PubMedCrossRef
17.
Zurück zum Zitat Sandman L, Munthe C. Shared decision-making, paternalism and patient choice. Health Care Anal. 2010;18(1):60–84.PubMedCrossRef Sandman L, Munthe C. Shared decision-making, paternalism and patient choice. Health Care Anal. 2010;18(1):60–84.PubMedCrossRef
18.
Zurück zum Zitat Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life threatening diseases. Hum Reprod Update. 2009;15:587–97.PubMedCrossRef Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life threatening diseases. Hum Reprod Update. 2009;15:587–97.PubMedCrossRef
19.
Zurück zum Zitat Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.PubMedCrossRef Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.PubMedCrossRef
20.
Zurück zum Zitat Penrose R, Beatty L, Mattiske J, Koczwara B. Fertility and cancer—a qualitative study of Australian cancer survivors. Support Care Cancer. 2011;20(6):1259–65.PubMedCrossRef Penrose R, Beatty L, Mattiske J, Koczwara B. Fertility and cancer—a qualitative study of Australian cancer survivors. Support Care Cancer. 2011;20(6):1259–65.PubMedCrossRef
21.
Zurück zum Zitat Woodruff TK. The Oncofertility Consortium—addressing fertility in young people with cancer. Nat Rev Clin Oncol. 2010;7(8):466–75.PubMedCrossRef Woodruff TK. The Oncofertility Consortium—addressing fertility in young people with cancer. Nat Rev Clin Oncol. 2010;7(8):466–75.PubMedCrossRef
22.
Zurück zum Zitat Patel A, Sreedevi M, Malapati R, Sutaria R, Schoenhage MB, Patal AR, et al. Reproductive health assessment for women with cancer: a pilot study. Am J Obstet Gynecol. 2009;201(2):191. e1–e4.PubMedCrossRef Patel A, Sreedevi M, Malapati R, Sutaria R, Schoenhage MB, Patal AR, et al. Reproductive health assessment for women with cancer: a pilot study. Am J Obstet Gynecol. 2009;201(2):191. e1–e4.PubMedCrossRef
23.
Zurück zum Zitat Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pre-treatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2011;118(6):1710–7.PubMedCrossRef Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pre-treatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2011;118(6):1710–7.PubMedCrossRef
24.
Zurück zum Zitat Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, et al. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005;34:94–8.PubMedCrossRef Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, et al. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005;34:94–8.PubMedCrossRef
25.
Zurück zum Zitat Reh AE, Lu L, Weinerman R, Grifo J, Krey L, Noyes N. Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 years. J Assist Reprod Genet. 2011;28(7):635–41.PubMedCrossRef Reh AE, Lu L, Weinerman R, Grifo J, Krey L, Noyes N. Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 years. J Assist Reprod Genet. 2011;28(7):635–41.PubMedCrossRef
26.
Zurück zum Zitat Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007;334:194–9.PubMedCrossRef Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ. 2007;334:194–9.PubMedCrossRef
27.
Zurück zum Zitat Azim HA, Peccatori FA, de Azambuja E, Piccart MJ. Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther. 2011;11(2):287–98.PubMedCrossRef Azim HA, Peccatori FA, de Azambuja E, Piccart MJ. Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther. 2011;11(2):287–98.PubMedCrossRef
28.
Zurück zum Zitat de Bree E, Makrigiannakis A, Askoxylakis J. Pregnancy after breast cancer: a comprehensive review. J Surg Oncol. 2010;101(6):534–42.PubMedCrossRef de Bree E, Makrigiannakis A, Askoxylakis J. Pregnancy after breast cancer: a comprehensive review. J Surg Oncol. 2010;101(6):534–42.PubMedCrossRef
29.
Zurück zum Zitat Meuller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR. Childbearing and survival after breast carcinoma in young women. Cancer. 2003;98(6):1131–40.CrossRef Meuller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR. Childbearing and survival after breast carcinoma in young women. Cancer. 2003;98(6):1131–40.CrossRef
30.
Zurück zum Zitat Sankila R, Heinavaara S, Hakulienen T. Survival of breast cancer patients after susbsequent term pregnancy “healthy mother effect”. Am J Obstet Gynecol. 1994;170:818–23.PubMed Sankila R, Heinavaara S, Hakulienen T. Survival of breast cancer patients after susbsequent term pregnancy “healthy mother effect”. Am J Obstet Gynecol. 1994;170:818–23.PubMed
31.
Zurück zum Zitat Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, et al. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat. 2011;129:309–17.PubMedCrossRef Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, et al. Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Res Treat. 2011;129:309–17.PubMedCrossRef
32.
Zurück zum Zitat Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004;100(3):465–9.PubMedCrossRef Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004;100(3):465–9.PubMedCrossRef
33.
Zurück zum Zitat Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, et al. Biological markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011;129:607–16.PubMedCrossRef Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, et al. Biological markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011;129:607–16.PubMedCrossRef
34.
Zurück zum Zitat Langagergaard V, Gislum M, Skriver MV, Norgard B, Lash TL, Rothman KJ, et al. Birth outcome in women with breast cancer. Br J Cancer. 2006;94(1):142–6.PubMedCrossRef Langagergaard V, Gislum M, Skriver MV, Norgard B, Lash TL, Rothman KJ, et al. Birth outcome in women with breast cancer. Br J Cancer. 2006;94(1):142–6.PubMedCrossRef
35.
Zurück zum Zitat Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7(4):394–403.PubMedCrossRef Arnon J, Meirow D, Lewis-Roness H, Ornoy A. Genetic and teratogenic effects of cancer treatments on gametes and embryos. Hum Reprod Update. 2001;7(4):394–403.PubMedCrossRef
36.
Zurück zum Zitat Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Human Reprod. 2001;16(4):632–7.CrossRef Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Human Reprod. 2001;16(4):632–7.CrossRef
37.
Zurück zum Zitat Quinn GP, Vadaparampil ST, Tollin S, Miree CA, Murphy D, Bover B, et al. BRCA carriers’ thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none. Fertil Steril. 2010;94(6):2473–5.PubMedCrossRef Quinn GP, Vadaparampil ST, Tollin S, Miree CA, Murphy D, Bover B, et al. BRCA carriers’ thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none. Fertil Steril. 2010;94(6):2473–5.PubMedCrossRef
38.
Zurück zum Zitat Quinn GP, Vadaparampil ST, Jacobsen PB, Knapp C, Keefe DL, Bell GE, et al. Frozen hope: fertility preservation for women with cancer. J Midwifery Womens Health. 2010;55:175–80.PubMedCrossRef Quinn GP, Vadaparampil ST, Jacobsen PB, Knapp C, Keefe DL, Bell GE, et al. Frozen hope: fertility preservation for women with cancer. J Midwifery Womens Health. 2010;55:175–80.PubMedCrossRef
39.
Zurück zum Zitat Baruch S. Preimplantation genetic diagnosis and parental preferences: beyond deadly disease. House J Health Law Policy. 2008;8:245–70. Baruch S. Preimplantation genetic diagnosis and parental preferences: beyond deadly disease. House J Health Law Policy. 2008;8:245–70.
40.
Zurück zum Zitat Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasis. J Natl Cancer Inst Monogr. 2005;3:87–90.CrossRef Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasis. J Natl Cancer Inst Monogr. 2005;3:87–90.CrossRef
41.
Zurück zum Zitat Niermeijer MF, de Wert G, Dondorp W. Preimplantation genetic diagnosis for cancer. Lancet Oncol. 2006;7:794–5.PubMedCrossRef Niermeijer MF, de Wert G, Dondorp W. Preimplantation genetic diagnosis for cancer. Lancet Oncol. 2006;7:794–5.PubMedCrossRef
42.
Zurück zum Zitat Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, et al. Discussion of fertility preservation with newly diagnosed patients; oncologist’s views. J Cancer Surviv. 2007;1(2):146–55.PubMedCrossRef Quinn GP, Vadaparampil ST, Gwede CK, Miree C, King LM, Clayton HB, et al. Discussion of fertility preservation with newly diagnosed patients; oncologist’s views. J Cancer Surviv. 2007;1(2):146–55.PubMedCrossRef
43.
Zurück zum Zitat Nakayama K, Liu P, Detry M, Schover LR, Milbourne A, Neumann J, et al. Receiving information on fertility-and menopause- related treatment effects among women who undergo hematopoietic stem cell transplanation: changes in perceived importance over time. Biol Blood Marrow Transplant. 2009;15:1465–74.PubMedCrossRef Nakayama K, Liu P, Detry M, Schover LR, Milbourne A, Neumann J, et al. Receiving information on fertility-and menopause- related treatment effects among women who undergo hematopoietic stem cell transplanation: changes in perceived importance over time. Biol Blood Marrow Transplant. 2009;15:1465–74.PubMedCrossRef
44.
Zurück zum Zitat Huyghe E, Sui D, Odensky E, Schover LR. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med. 2009;6:149–63.PubMedCrossRef Huyghe E, Sui D, Odensky E, Schover LR. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med. 2009;6:149–63.PubMedCrossRef
45.
Zurück zum Zitat Arora NK, Hamilton AS, Potosky AL, Rowland JH, Aziz NM, Bellizzi KM, et al. Population-based survivorship research using cancer registries: a study of non-Hodkin’s lymphoma survivors. J Cancer Surviv. 2007;1:49–63.PubMedCrossRef Arora NK, Hamilton AS, Potosky AL, Rowland JH, Aziz NM, Bellizzi KM, et al. Population-based survivorship research using cancer registries: a study of non-Hodkin’s lymphoma survivors. J Cancer Surviv. 2007;1:49–63.PubMedCrossRef
Metadaten
Titel
Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors
verfasst von
Erin Ebbel Niemasik
Joseph Letourneau
Daniel Dohan
Audra Katz
Michelle Melisko
Hope Rugo
Mitchell Rosen
Publikationsdatum
01.09.2012
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2012
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0227-9

Weitere Artikel der Ausgabe 3/2012

Journal of Cancer Survivorship 3/2012 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.